![]() |
||
|---|---|---|
| 【ProductName】 |
FMO3 Antibody Blocking Peptide |
|
| 【Cat NO.】 |
K109630P-Ag |
|
| 【Source】 |
Synthetic |
|
| 【Storage】 |
Store at -20℃,2 years.Avoid freeze/thaw cycles. |
|
| 【Appearance】 |
Lyophilized powder |
|
| 【Swiss Prot】 |
P31513 |
|
| 【Gene ID】 |
2328 |
|
| 【Application】 |
Blocking Peptide of K109630P Antibody |
|
| 【Purification】 |
HPLC |
|
| 【Activity】 |
Not tested |
|
| 【Note】 |
Please allow the product to equilibrate to room temperature in a dry environment before opening the packaging. |
|
![]() |
||
Essential hepatic enzyme that catalyzes the oxygenation of a wide variety of nitrogen- and sulfur-containing compounds including drugs as well as dietary compounds (PubMed:10759686, PubMed:30381441). Plays an important role in the metabolism of trimethylamine (TMA), via the production of trimethylamine N-oxide (TMAO) metabolite (PubMed:9776311). TMA is generated by the action of gut microbiota using dietary precursors such as choline, choline containing compounds, betaine or L-carnitine. By regulating TMAO concentration, FMO3 directly impacts both platelet responsiveness and rate of thrombus formation?.